Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
30,993,684
-
Shares change
-
-4,518,928
-
Total reported value, excl. options
-
$101,545,957
-
Value change
-
-$24,704,471
-
Put/Call ratio
-
44%
-
Number of buys
-
42
-
Number of sells
-
-36
-
Price
-
$3.26
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2021
116 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2021.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,993,684 shares
of 129,337,627 outstanding shares and own 23.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,550,604 shares), VANGUARD GROUP INC (7,056,461 shares), STATE STREET CORP (2,145,952 shares), GEODE CAPITAL MANAGEMENT, LLC (2,109,160 shares), Nuveen Asset Management, LLC (1,593,961 shares), NORTHERN TRUST CORP (1,082,518 shares), CITADEL ADVISORS LLC (1,021,707 shares), D. E. Shaw & Co., Inc. (896,057 shares), Bank of New York Mellon Corp (477,291 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (299,431 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.